Fingerprint
Dive into the research topics of 'Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically